Literature DB >> 2457327

Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity.

W M Bennett1, L M Mela-Riker, D C Houghton, D N Gilbert, W C Buss.   

Abstract

Aminoglycoside antibiotics achieve bacterial killing by binding to bacterial ribosomes and inhibiting protein synthesis. To examine whether similar mechanisms could be present in renal tubular cells prior to the onset of overt proximal tubular necrosis due to these drugs, we isolated microsomes from Fischer rats given 20 mg/kg gentamicin every 12 h subcutaneously for 2 days and from vehicle-injected controls. Concomitant studies of renal structure, function, and mitochondrial respiration were carried out. [3H]leucine incorporation into renal microsomes of treated animals was reduced by 21.9% (P less than 0.01), whereas brain and liver microsomes from the same animals were unaffected. Gentamicin concentration in the renal microsomal preparation was 56 micrograms/ml, a value 7- to 10-fold above concentrations necessary to inhibit bacterial growth. Conventional renal function studies were normal (blood urea, serum creatinine, creatinine clearance). Treated animals showed only a mild reduction of inulin clearance, 0.71 compared with 0.93 ml.min-1.100 g-1 in controls (P less than 0.05), and an increase in urinary excretion of N-acetylglucosaminidase of 20 compared with 14.8 units/l (P less than 0.05). Renal slice transport of p-aminohippuric acid, tetraethylammonium, and the fractional excretion of sodium were well preserved. There was no evidence, as seen by light microscopy, of proximal tubular necrosis. Mitochondrial cytochrome concentrations were normal and respiratory activities only slightly reduced. Processes similar to those responsible for bacterial killing could be involved in experimental gentamicin nephrotoxicity before overt cellular necrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457327     DOI: 10.1152/ajprenal.1988.255.2.F265

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993.

Authors: 
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 2.  Pharmacological considerations for the proper clinical use of aminoglycosides.

Authors:  Spyridon Pagkalis; Elpis Mantadakis; Michael N Mavros; Christina Ammari; Matthew E Falagas
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

Review 3.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

4.  Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.

Authors:  Vaishali S Janve; Ciria C Hernandez; Kelienne M Verdier; Ningning Hu; Robert L Macdonald
Journal:  Ann Neurol       Date:  2016-05       Impact factor: 10.422

5.  Cellular toxicity of aminoglycoside antibiotics in G418-sensitive and -resistant LLC-PK1 cells.

Authors:  M Takano; M Okuda; M Yasuhara; R Hori
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 6.  Fluid, electrolyte and acid-base disorders associated with antibiotic therapy.

Authors:  R Zietse; R Zoutendijk; E J Hoorn
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.